321 related articles for article (PubMed ID: 11458069)
21. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
22. Relevance and variability of the severity of incontinence, and increased daytime and night-time voiding frequency, associated with quality of life in men with lower urinary tract symptoms.
Haltbakk J; Hanestad BR; Hunskaar S
BJU Int; 2005 Jul; 96(1):83-7. PubMed ID: 15963126
[TBL] [Abstract][Full Text] [Related]
23. Significance of nocturnal hesitancy in treatment of men with lower urinary tract symptoms.
Ku JH; Um JM; Shin JW; Yang JH; Paick JS
Urology; 2006 May; 67(5):978-83. PubMed ID: 16698358
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of lower urinary tract symptoms in men aged 45-79 years: a population-based study of 40 000 Swedish men.
Andersson SO; Rashidkhani B; Karlberg L; Wolk A; Johansson JE
BJU Int; 2004 Aug; 94(3):327-31. PubMed ID: 15291861
[TBL] [Abstract][Full Text] [Related]
25. Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.
McVary KT; Roehrborn CG; Kaminetsky JC; Auerbach SM; Wachs B; Young JM; Esler A; Sides GD; Denes BS
J Urol; 2007 Apr; 177(4):1401-7. PubMed ID: 17382741
[TBL] [Abstract][Full Text] [Related]
26. Impact of lower urinary tract symptoms on quality of life using Functional Assessment Cancer Therapy scale.
Batista-Miranda JE; Molinuevo B; Pardo Y
Urology; 2007 Feb; 69(2):285-8. PubMed ID: 17320665
[TBL] [Abstract][Full Text] [Related]
27. [Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging.male (MSAM-7)].
Rosen R; Altwein J; Boyle P; Kirby RS; Lukacs B; Meuleman E; O'Leary MP; Puppo P; Chris R; Giuliano F
Prog Urol; 2004 Jun; 14(3):332-44. PubMed ID: 15373175
[TBL] [Abstract][Full Text] [Related]
28. Impact of LUTS using bother index in DAN-PSS-1 questionnaire.
Häkkinen JT; Hakama M; Huhtala H; Shiri R; Auvinen A; Tammela TL; Koskimäki J
Eur Urol; 2007 Feb; 51(2):473-7; discussion 477-8. PubMed ID: 16879907
[TBL] [Abstract][Full Text] [Related]
29. Tolterodine extended release attenuates lower urinary tract symptoms in men with benign prostatic hyperplasia.
Kaplan SA; Walmsley K; Te AE
J Urol; 2005 Dec; 174(6):2273-5. discussion 2275-6. PubMed ID: 16280803
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.
Yang Y; Zhao XF; Li HZ; Wang W; Zhang Y; Xiao H; Zhang X
Chin Med J (Engl); 2007 Mar; 120(5):370-4. PubMed ID: 17376305
[TBL] [Abstract][Full Text] [Related]
31. Association between erectile dysfunction and lower urinary tract symptoms due to benign prostatic hyperplasia in Nigerian men.
Ikuerowo SO; Akindiji YO; Akinoso OA; Akinlusi FM; Esho JO
Urol Int; 2008; 80(3):296-9. PubMed ID: 18480635
[TBL] [Abstract][Full Text] [Related]
32. Relationship between lower urinary tract symptoms and objective measures of benign prostatic hyperplasia: a Chinese survey.
Wang JY; Liu M; Zhang YG; Zeng P; Ding Q; Huang J; He DL; Song B; Kong CZ; Pang J
Chin Med J (Engl); 2008 Oct; 121(20):2042-5. PubMed ID: 19080272
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of lower urinary tract symptoms (LUTS) in stroke patients: a cross-sectional, clinical survey.
Tibaek S; Gard G; Klarskov P; Iversen HK; Dehlendorff C; Jensen R
Neurourol Urodyn; 2008; 27(8):763-71. PubMed ID: 18551565
[TBL] [Abstract][Full Text] [Related]
34. Association between lower urinary tract symptoms and erectile dysfunction.
Aslan G; Cavus E; Karas H; Oner O; Duran F; Esen A
Arch Androl; 2006; 52(3):155-62. PubMed ID: 16574595
[TBL] [Abstract][Full Text] [Related]
35. Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.
Schwartz EJ; Lepor H
J Urol; 1999 Apr; 161(4):1185-8. PubMed ID: 10081866
[TBL] [Abstract][Full Text] [Related]
36. [Quality of life and symptomatology in benign prostate hyperplasia in active Spanish population].
Gómez Acebo A; Rodríguez Vallejo JM; Rodríguez Mora VI; García Alcázar I
Med Clin (Barc); 2000; 114 Suppl 3():81-9. PubMed ID: 10994569
[TBL] [Abstract][Full Text] [Related]
37. Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function.
Marszalek M; Wehrberger C; Hochreiter W; Temml C; Madersbacher S
J Urol; 2007 May; 177(5):1815-9. PubMed ID: 17437827
[TBL] [Abstract][Full Text] [Related]
38. [Evaluation of sexual function in men with symptomatic benign prostatic hyperplasia].
Shao Q; Song J; Guo YW; Lu WC; Du LD
Zhonghua Nan Ke Xue; 2005 Jul; 11(7):505-7. PubMed ID: 16078666
[TBL] [Abstract][Full Text] [Related]
39. Prospective evaluation of the effects of prostatectomy on symptoms and quality of life.
Derrett S; Paul C; Herbison P
N Z Med J; 2001 Jun; 114(1134):276-9. PubMed ID: 11480508
[TBL] [Abstract][Full Text] [Related]
40. Comparison of two alpha1-adrenoceptor antagonists, naftopidil and tamsulosin hydrochloride, in the treatment of lower urinary tract symptoms with benign prostatic hyperplasia: a randomized crossover study.
Nishino Y; Masue T; Miwa K; Takahashi Y; Ishihara S; Deguchi T
BJU Int; 2006 Apr; 97(4):747-51, discussion 751. PubMed ID: 16536766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
